Filing Details

Accession Number:
0001209191-22-060691
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-12 16:25:17
Reporting Period:
2022-12-08
Accepted Time:
2022-12-12 16:25:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1841387 Candel Therapeutics Inc. CADL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1451805 Jason Amello C/O Candel Therapeutics, Inc.
117 Kendrick St., Suite 450
Needham MA 02494
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-08 3,100 $1.69 3,100 No 4 P Direct
Common Stock Acquisiton 2022-12-09 2,468 $1.93 5,568 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.78. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.85 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.